Latest News


2020.05.22 | Research news

Researcher profile: Camila Esguerra

Dr Camila Esguerra joined NCMM in 2014. Her research involves using zebrafish as a model to study brain function in health and disease. In this profile article, Camila discusses her research career so far, the benefits of using zebrafish in translational research, and her visions and plans for the future.

Image: Shutterstock

2020.05.07 | Research news

EMBL-EBI launches COVID-19 Data Platform

EMBL's European Bioinformatics Institute (EMBL-EBI) at Hinxton, UK, has created the COVID-19 Data Portal to help coordinate viral genome sequence data across Europe

2020.04.21 | News from the management

Nordic EMBL Partnership awarded NordForsk funding

Grant awarded as part of Nordic Research Infrastructure Hubs call

LRRK2, DANi-011A, iPSC line generated by Sendai virus reprogramming. A) iPSCs stain positive for Alkaline phosphatase. B) Expression of pluripotent markers OCT4 and NANOG. C) DNA sequencing confirms the LRRK2 G2019S variant. D) Reprogrammed iPSCs no longer contain Sendai viruses. Credit: Denham group

2020.04.16 | Publication, Knowledge exchange

New pluripotent stem cell line generated from a Parkinson’s disease patient is aimed at studying PD mechanisms and as a drug-screening platform

Denham group at DANDRITE and colleague researchers have developed a new stem cell line (DANi-011A) from a Parkinson’s disease (PD) patient carrying a LRRK2 p.G2019S mutation that is identified in inherited and sporadic cases of PD. The established cell line enables in vitro modelling of PD and the development of potential treatment strategies for…

Showing results 5 to 8 of 53

Previous 1 2 3 4 5 6 7 8 9 10 Next

Upcoming Partnership Events